Insider Trading activities at Rigel Pharmaceuticals Inc (RIGL)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rigel Pharmaceuticals Inc (RIGL) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rigel Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1034842.

Total stock buying since 2015: $1,702,398.
Total stock sales since 2015: $1,863,950.
Total stock option exercises since 2015: $2,763,084.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Rigel Pharmaceuticals Inc* (*RIGL*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2025	0	$0	19,830	$424,175	96,500	$2,062,284
2024	0	$0	80,041	$90,909	0	$0
2023	0	$0	36,506	$62,429	0	$0
2022	1,000,000	$688,000	0	$0	0	$0
2019	50,000	$106,500	0	$0	0	$0
2018	314,000	$907,898	189,500	$659,045	169,500	$397,635
2017	0	$0	110,000	$415,455	100,000	$214,000
2016	0	$0	5,303	$21,212	0	$0
2015	0	$0	51,666	$190,725	41,666	$89,165

Table 2. Monthly summary of insider trading at *Rigel Pharmaceuticals Inc* (*RIGL*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2025-12	0	$0	0	$0	6,500	$136,285
2025-02	0	$0	19,830	$424,175	0	$0
2025-01	0	$0	0	$0	90,000	$1,925,999
2024-02	0	$0	80,041	$90,909	0	$0
2023-02	0	$0	36,506	$62,429	0	$0
2022-06	1,000,000	$688,000	0	$0	0	$0
2019-05	50,000	$106,500	0	$0	0	$0
2018-10	0	$0	10,000	$31,200	0	$0
2018-09	100,000	$325,550	169,500	$593,365	169,500	$397,635
2018-08	214,000	$582,348	0	$0	0	$0
2018-07	0	$0	5,000	$13,930	0	$0
2018-04	0	$0	5,000	$20,550	0	$0
2017-11	0	$0	100,000	$390,000	100,000	$214,000
2017-07	0	$0	5,000	$13,425	0	$0
2017-01	0	$0	5,000	$12,030	0	$0
2016-08	0	$0	5,303	$21,212	0	$0
2015-06	0	$0	41,666	$153,205	41,666	$89,165
2015-04	0	$0	10,000	$37,520	0	$0

Table 3. Detailed insider trading at *Rigel Pharmaceuticals Inc* (*RIGL*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2025-12-22	Schorno Dean L (EVP & Chief Financial Officer)	Option Ex	6,500	20.97	136,285
2025-02-05	Santos David A (EVP, Chief Commercial Officer)	Sale	1,796	21.93	39,379
2025-02-05	Furey Raymond J. (EVP, GC, CCO & Corp Sec)	Sale	1,339	21.93	29,358
2025-02-05	Schorno Dean L (EVP & Chief Financial Officer)	Sale	1,734	21.93	38,019
2025-02-05	Rodriguez Raul R (CEO, President)	Sale	4,400	21.93	96,474
2025-02-04	Santos David A (EVP, Chief Commercial Officer)	Sale	2,125	20.92	44,457
2025-02-04	Furey Raymond J. (EVP, GC, CCO & Corp Sec)	Sale	1,448	20.92	30,293
2025-02-04	Schorno Dean L (EVP & Chief Financial Officer)	Sale	2,036	20.92	42,595
2025-02-04	Rodriguez Raul R (CEO, President)	Sale	4,952	20.92	103,600
2025-01-24	Rodriguez Raul R (CEO, President)	Option Ex	90,000	21.40	1,925,999
2024-02-05	Santos David A (EVP, Chief Commercial Officer)	Sale	8,918	1.14	10,166
2024-02-05	Schorno Dean L (EVP & Chief Financial Officer)	Sale	7,027	1.14	8,010
2024-02-05	Rodriguez Raul R (CEO, President)	Sale	30,545	1.14	34,821
2024-02-02	Santos David A (EVP, Chief Commercial Officer)	Sale	5,601	1.13	6,329
2024-02-02	Schorno Dean L (EVP & Chief Financial Officer)	Sale	5,601	1.13	6,329
2024-02-02	Rodriguez Raul R (CEO, President)	Sale	22,349	1.13	25,254
2023-02-06	Rodriguez Raul R (CEO, President)	Sale	20,340	1.75	35,595
2023-02-02	Santos David A (EVP, Chief Commercial Officer)	Sale	5,388	1.66	8,944
2023-02-02	Dummer Wolfgang (EVP & CMO)	Sale	5,389	1.66	8,945
2023-02-02	Schorno Dean L (EVP & Chief Financial Officer)	Sale	5,389	1.66	8,945
2022-06-09	Rodriguez Raul R (CEO, President)	Buy	1,000,000	.69	688,000
2019-05-22	Schorno Dean L (EVP &Chief Financial Officer)	Buy	50,000	2.13	106,500
2018-10-12	Cabatuan Nelson (Principal Accounting Officer)	Sale	10,000	3.12	31,200
2018-09-17	Duliege Anne-marie (EVP & Chief Medical Officer)	Sale	153,000	3.50	535,500
2018-09-17	Duliege Anne-marie (EVP & Chief Medical Officer)	Option Ex	153,000	2.33	355,725
2018-09-11	Mayer Eldon C. Iii (EVP & Chief Commercial Officer)	Buy	50,000	3.23	161,350
2018-09-10	Mayer Eldon C. Iii (EVP & Chief Commercial Officer)	Buy	50,000	3.28	164,200
2018-09-04	Duliege Anne-marie (EVP & Chief Medical Officer)	Sale	16,500	3.51	57,865
2018-09-04	Duliege Anne-marie (EVP & Chief Medical Officer)	Option Ex	16,500	2.54	41,910
2018-08-23	Mayer Eldon C. Iii (EVP & Chief Commercial Officer)	Buy	100,000	2.82	282,300
2018-08-17	Rodriguez Raul R (CEO, President)	Buy	114,000	2.63	300,048
2018-07-02	Duliege Anne-marie (EVP & Chief Medical Officer)	Sale	5,000	2.79	13,930
2018-04-20	Duliege Anne-marie (EVP & Chief Medical Officer)	Sale	5,000	4.11	20,550
2017-11-03	Maynard Ryan D (EVP & CFO)	Sale	100,000	3.90	390,000
2017-11-03	Maynard Ryan D (EVP & CFO)	Option Ex	100,000	2.14	214,000
2017-07-05	Duliege Anne-marie (Chief Medical Officer)	Sale	5,000	2.69	13,425
2017-01-03	Duliege Anne-marie (Chief Medical Officer)	Sale	5,000	2.41	12,030
2016-08-30	Payan Donald G (EVP, Pres. Discovery&Research)	Sale	5,303	4.00	21,212
2015-06-10	Payan Donald G (EVP, Pres. Discovery&Research)	Sale	41,666	3.68	153,205
2015-06-10	Payan Donald G (EVP, Pres. Discovery&Research)	Option Ex	41,666	2.14	89,165
2015-04-01	Payan Donald G (EVP, Pres. Discovery&Research)	Sale	10,000	3.75	37,520

Insider trading activities including stock purchases, stock sales, and option exercises of RIGL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rigel Pharmaceuticals Inc (symbol RIGL, CIK number 1034842) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month